Antimalarial Chemotherapy. Mechanisms of Action, Resistance and New Directions in Drug Discovery

Abstract

I. Introduction The Need for New Approaches to Antimalarial Chemotherapy Philip J. Rosenthal and Louis H. Miller The History of Antimalarial Drugs Steven R. Meshnick and Mary J. Dobson Transport and Trafficking in Plasmodium-Infected Red Cells Kasturi Haldar and Thomas Akompong The Plasmodium Food Vacuole Ritu Banerjee and Daniel E. Goldberg Clinical and Public Health Implications of Antimalarial Drug Resistance Piero L. Olliaro and Peter B. Bloland II. Established Antimalarial Drugs and Compounds Under Clinical Development Chloroquine and Other Quinoline Antimalarials Leann Tilley, Paul Loria, and Mick Foley 8-Aminoquinolines Ralf P. Brueckner, Colin Ohrt, J. Kevin Baird, and Wilbur K. Milhous Mechanisms of Quinoline Resistance Grant Dorsey, David A. Fidock, Thomas E. Wellems, and Philip J. Rosenthal Folate Antagonists and Mechanisms of Resistance Christopher V. Plowe Artemisinin and Its Derivatives Steven R. Meshnick. Atovaquone-Proguanil Combination, Akhil B. Vaidya The Antimalarial Drug Portfolio and Research Pipeline Piero L. Olliaro and Wilbur K. Milhous III. New Compounds, New Approaches, and New Targets Novel Quinoline Antimalarials Paul A. Stocks, Kaylene J. Raynes, and Stephen A. Ward New Antimalarial Trioxanes and Endoperoxides Gary H. Posner, Mikhail Krasavin, Michael McCutchen, Poonsakdi Ploypradith, John P. Maxwell, Jeffrey S. Elias, and Michael H. Parker Antibiotics and the Plasmodial Plastid Organelle Barbara Clough and R. J. M. (Iain) Wilson Fresh Paradigms for Curative Antimetabolites Pradipsinh K. Rathod. Iron Chelators, Mark Loyevsky and Victor R. Gordeuk Protease Inhibitors Philip J. Rosenthal Inhibitors of Phospholipid Metabolism Henri Joseph Vial and Michele Calas Development of New Malaria Chemotherapy by Utilization of Parasite-Induced Transport Annette M. Gero and Alexander L. Weis